Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

5.1K
5.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.

Kidney international reports·2026
Same author

Recurrent Neuro-Renal Syndrome With Acute Kidney Injury From Anti-Pan-Neurofascin Antibody Resurgence: A Case Report.

Kidney medicine·2026
Same author

Thrombotic Microangiopathy, Cryoglobulinemia, and Acute Kidney Injury in Patients With Monoclonal Gammopathy: A Case Series.

American journal of hematology·2026
Same author

Parathyroid histology in normocalcemic and hypercalcemic primary hyperparathyroidism with hypercalciuric renal stones.

Journal of the Endocrine Society·2026
Same author

Knock-down of the long isoform of the WNK1 kinase mitigates the anti-glomerular basement membrane glomerulonephritis in mice.

Scientific reports·2026
Same author

Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death.

JCI insight·2026
Same journal

[Case no. 2. Pseudotumoral pulmonary IgG4 disease].

Annales de pathologie·2026
Same journal

[Diffuse large B-cell lymphoma-NOS , high-grade B-cell lymphomas and Burkitt lymphoma: Updates].

Annales de pathologie·2026
Same journal

[Ironing out the diagnosis].

Annales de pathologie·2026
Same journal

[Ecological transformation and quality of surgical pathological analysis: Not such an insoluble equation].

Annales de pathologie·2026
Same journal

[Cerebrospinal fluid in the context of headaches with decreased visual acuity].

Annales de pathologie·2026
Same journal

[Facial granulomatous lesion in a traveler].

Annales de pathologie·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

13.4K

[Amyloidosis - The pathologist's perspective].

David Buob1

  • 1Service d'anatomie et cytologie pathologiques, hôpital Tenon, Paris Sorbonne université, Assistance publique-Hôpitaux de Paris, 4, rue de la Chine, 75970 Paris, France.

Annales De Pathologie
|October 9, 2024
PubMed
Summary
This summary is machine-generated.

Pathologists are crucial for diagnosing and typing amyloidosis, even with new imaging techniques. Familiarity with Congo red staining and immunohistochemistry pitfalls is essential for accurate diagnosis.

Keywords:
AmyloidosisAmyloseCongo RedImmunohistochemistryImmunohistochimieRouge Congo

More Related Videos

Performing and Processing FNA of Anterior Fat Pad for Amyloid
09:41

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Published on: October 30, 2010

55.1K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.2K

Related Experiment Videos

Last Updated: Jun 11, 2025

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

13.4K
Performing and Processing FNA of Anterior Fat Pad for Amyloid
09:41

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Published on: October 30, 2010

55.1K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.2K

Area of Science:

  • Pathology
  • Medical Diagnostics
  • Histopathology

Context:

  • Transthyretin amyloidosis diagnosis is evolving with scintigraphy.
  • Pathological diagnosis remains essential for definitive amyloidosis typing.
  • Challenges exist in histological interpretation and immunohistochemistry.

Purpose:

  • To highlight the central role of pathologists in amyloidosis diagnosis and subtyping.
  • To identify common pitfalls in anatomo-pathological diagnosis of amyloidosis.
  • To recommend expert center consultation for complex cases.

Summary:

  • Pathological assessment is vital for amyloidosis diagnosis and typing, complementing scintigraphy.
  • Known pitfalls in Congo red staining and immunohistochemistry can hinder accurate diagnosis.
  • Expert centers are recommended for challenging cases or when typing is uncertain.

Impact:

  • Improved diagnostic accuracy for amyloidosis.
  • Enhanced understanding of histological diagnostic challenges.
  • Guidance on utilizing expert centers for complex amyloidosis cases.